
        <!DOCTYPE html>
        <html>
        <head>
            <meta charset="UTF-8">
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <title>CASSIA Cell Type Annotation Summary (Breadth-First Analysis)</title>
            <style>
                :root {
                    --primary-color: #2563eb;
                    --secondary-color: #0891b2;
                    --accent-color: #4f46e5;
                    --light-bg: #f3f4f6;
                    --border-color: #e5e7eb;
                    --text-color: #1f2937;
                    --text-light: #6b7280;
                }
                
                body {
                    font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
                    line-height: 1.6;
                    color: var(--text-color);
                    background-color: #ffffff;
                    margin: 0;
                    padding: 0;
                }
                
                .container {
                    max-width: 900px;
                    margin: 0 auto;
                    padding: 2rem;
                }
                
                header {
                    text-align: center;
                    margin-bottom: 2.5rem;
                    border-bottom: 2px solid var(--border-color);
                    padding-bottom: 1rem;
                }
                
                h1 {
                    color: var(--primary-color);
                    font-size: 2.5rem;
                    margin-bottom: 0.5rem;
                }
                
                .subtitle {
                    color: var(--text-light);
                    font-size: 1.2rem;
                    margin-top: 0;
                }
                
                section {
                    margin-bottom: 2.5rem;
                    background-color: white;
                    border-radius: 0.5rem;
                    box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
                    padding: 1.5rem;
                    border-left: 4px solid var(--primary-color);
                }
                
                h2 {
                    color: var(--primary-color);
                    font-size: 1.8rem;
                    margin-top: 0;
                    border-bottom: 1px solid var(--border-color);
                    padding-bottom: 0.5rem;
                }
                
                h3 {
                    color: var(--secondary-color);
                    font-size: 1.3rem;
                    margin: 1.5rem 0 0.5rem;
                }
                
                ul, ol {
                    padding-left: 1.5rem;
                }
                
                li {
                    margin-bottom: 0.5rem;
                }
                
                .final-annotation {
                    background-color: #ecfdf5;
                    border-left: 4px solid #10b981;
                }
                
                .final-annotation h2 {
                    color: #10b981;
                }
                
                .iteration {
                    margin-bottom: 1.5rem;
                    background-color: var(--light-bg);
                    border-radius: 0.5rem;
                    padding: 1.5rem;
                    border-left: 4px solid var(--secondary-color);
                }
                
                .iteration-title {
                    font-size: 1.5rem;
                    color: var(--secondary-color);
                    margin-top: 0;
                    border-bottom: 1px solid var(--border-color);
                    padding-bottom: 0.5rem;
                }
                
                .gene-list {
                    display: flex;
                    flex-wrap: wrap;
                    gap: 0.5rem;
                    margin: 1rem 0;
                }
                
                .gene-badge {
                    background-color: var(--accent-color);
                    color: white;
                    padding: 0.3rem 0.7rem;
                    border-radius: 1rem;
                    font-size: 0.9rem;
                    font-weight: 500;
                }
                
                .sub-section {
                    background-color: white;
                    border-radius: 0.3rem;
                    padding: 1rem;
                    margin-top: 1rem;
                }
                
                code {
                    font-family: ui-monospace, monospace;
                    font-size: 0.9em;
                }
                
                .marker-category {
                    margin-bottom: 1rem;
                }
                
                .marker-category-title {
                    font-weight: 600;
                    margin-bottom: 0.5rem;
                    color: var(--secondary-color);
                }
                
                .hypothesis-list {
                    display: flex;
                    flex-direction: column;
                    gap: 0.8rem;
                }
                
                .hypothesis-item {
                    padding-left: 1.5rem;
                    position: relative;
                    margin-bottom: 0.5rem;
                }
                
                .hypothesis-number {
                    position: absolute;
                    left: 0;
                    font-weight: 600;
                    color: var(--accent-color);
                }
                
                .hypothesis-item-continued {
                    padding-left: 1.5rem;
                    margin-top: -0.3rem;
                    color: var(--text-light);
                }
            </style>
        </head>
        <body>
            <div class="container">
                <header>
                    <h1>CASSIA Cell Type Annotation Summary (Breadth-First Analysis)</h1>
                    <p class="subtitle">Single-cell RNA-seq Analysis Report</p>
                </header>
                
                <section>
                    <h2>Overview</h2>
                    <div class="content">
                        This report summarizes the iterative gene expression analysis performed by CASSIA to annotate a specific cell cluster. The analysis involved 5 iterations, examining a total of 30 unique genes to refine the cell type annotation.
                    </div>
                </section>
                
                <section>
                    <h2>Initial Assessment</h2>
                    <div class="content">
                        The initial hypothesis was that the cluster represented Enteric Glial Cells, supported by markers like PLP1, SOX10, and PTPRZ1. However, uncertainty arose due to the presence of non-exclusively glial markers (SPP1, LPL), ambiguity regarding ENS myelination, and the expression of L1CAM, NRXN1/NRXN3 suggesting interactions with other cell types. The high expression of NKAIN3 also warranted further investigation.
                    </div>
                </section>
        
                    <section>
                        <h2>Iteration 1</h2>
                        
                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To confirm glial identity and rule out hematopoietic or endothelial contamination by checking canonical glial markers (GFAP, S100B) and absence of pan-hematopoietic (CD45) and endothelial (CD34) markers.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To investigate myelinating vs. non-myelinating glia subtypes using specific markers (MPZ, MBP for myelinating; ERBB3, NGFR for immature/non-myelinating).</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To explore the possibility of enteric glial progenitors or neural stem cells by checking for associated markers (SOX9, NES, PROM1, CD133).</div></div>
                            </div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">GFAP</span><span class="gene-badge">S100B</span><span class="gene-badge">CD34</span><span class="gene-badge">CD45</span><span class="gene-badge">MPZ</span><span class="gene-badge">MBP</span><span class="gene-badge">ERBB3</span><span class="gene-badge">NGFR</span><span class="gene-badge">SOX9</span><span class="gene-badge">NES</span><span class="gene-badge">PROM1</span><span class="gene-badge">CD133</span></div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                High expression of S100B, MPZ, ERBB3, NES, and NGFR was observed. Low expression of MBP, PROM1, and SOX9 was noted. The absence of CD133, CD34, CD45, and GFAP from the differential expression list was highlighted as a critical gap. These findings suggested a complex glial population with both myelinating/myelin-associated and immature/non-myelinating components, with progenitor characteristics not being dominant.
                            </div>
                        </div>
                    </section>
                
                    <section>
                        <h2>Iteration 2</h2>
                        
                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To confirm expression levels of GFAP, CD34, and CD45, which were missing from the previous differential expression list, to solidify mature glial identity and rule out contamination.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To further dissect myelinating characteristics, specifically by checking KROX20 (EGR2) and re-evaluating SOX10, FOXD3, and PLP1 alongside MPZ.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To understand the specific contribution of initially noted non-exclusively glial markers (CDH19, L1CAM, NRXN1, NRXN3, SPP1, LPL, NKAIN3) to the phenotype of this specific glial population.</div></div>
                            </div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">GFAP</span><span class="gene-badge">CD34</span><span class="gene-badge">CD45</span><span class="gene-badge">KROX20</span><span class="gene-badge">SOX10</span><span class="gene-badge">FOXD3</span><span class="gene-badge">PLP1</span><span class="gene-badge">CDH19</span><span class="gene-badge">L1CAM</span><span class="gene-badge">NRXN1</span><span class="gene-badge">NRXN3</span><span class="gene-badge">SPP1</span><span class="gene-badge">LPL</span><span class="gene-badge">NKAIN3</span></div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                Very high and widespread expression of PLP1, SOX10, L1CAM, NRXN1, NRXN3, FOXD3, CDH19, SPP1, LPL, and NKAIN3 was observed, confirming initial glial and neural crest origin and suggesting these genes are integral to the phenotype. The continued absence of CD34, CD45, GFAP, and KROX20 from the differential expression list remained a critical missing piece.
                            </div>
                        </div>
                    </section>
                
                    <section>
                        <h2>Iteration 3</h2>
                        
                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To obtain expression data for GFAP, CD34, and CD45 to confirm mature enteric glia and rule out contamination.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To further clarify myelinating status by checking KROX20 and PMP22, and re-evaluating MBP, to understand the extent of myelinating glia. SNAI2 was also checked for insights into Schwann cell development.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To explore potential functional states or subtypes related to metabolic support or reactive states by checking APOE, CLU, CST3, and AQP4.</div></div>
                            </div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">GFAP</span><span class="gene-badge">CD34</span><span class="gene-badge">CD45</span><span class="gene-badge">KROX20</span><span class="gene-badge">MBP</span><span class="gene-badge">PMP22</span><span class="gene-badge">SNAI2</span><span class="gene-badge">APOE</span><span class="gene-badge">CLU</span><span class="gene-badge">CST3</span><span class="gene-badge">AQP4</span></div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                High expression of CLU, CST3, APOE, and PMP22 was observed, suggesting significant metabolic/supportive roles and strengthening the presence of a myelinating/myelin-associated population. MBP remained low. The continued absence of GFAP, KROX20, CD34, CD45, AQP4, and SNAI2 from the differential expression list was noted as a critical gap.
                            </div>
                        </div>
                    </section>
                
                    <section>
                        <h2>Iteration 4</h2>
                        
                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To obtain essential expression data for GFAP, CD34, and CD45 to confirm glial maturity and rule out contamination.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To clarify specific commitment to myelination and developmental stage by re-evaluating KROX20, SOX9, and SOX2.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To refine the specific subtype of enteric glia by examining a broader panel of established enteric glial markers (S100B, PTPRZ1, CHL1, CADM2).</div></div>
                            </div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">GFAP</span><span class="gene-badge">CD34</span><span class="gene-badge">CD45</span><span class="gene-badge">KROX20</span><span class="gene-badge">SOX9</span><span class="gene-badge">SOX2</span><span class="gene-badge">S100B</span><span class="gene-badge">PTPRZ1</span><span class="gene-badge">CHL1</span><span class="gene-badge">CADM2</span></div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                Very high and widespread expression of S100B, PTPRZ1, CHL1, CADM2, and SOX2 was observed, reinforcing general glial and neural adhesion characteristics, and suggesting immature/progenitor-like glia. SOX9 remained low. The continued absence of GFAP, KROX20, CD34, and CD45 from the differential expression list was highlighted as a critical impediment.
                            </div>
                        </div>
                    </section>
                
                    <section>
                        <h2>Iteration 5</h2>
                        
                        <div class="sub-section">
                            <h3>Hypotheses</h3>
                            <div class="content">
                                <div class="hypothesis-list"><div class="hypothesis-item"><span class="hypothesis-number">1.</span> To obtain paramount expression data for GFAP, CD34, and CD45 to confirm glial maturity and cluster purity.</div><div class="hypothesis-item"><span class="hypothesis-number">2.</span> To resolve ambiguity regarding myelination by re-examining KROX20, MBP, MPZ, and PMP22.</div><div class="hypothesis-item"><span class="hypothesis-number">3.</span> To further explore progenitor characteristics and developmental plasticity by investigating SNAI2, FOXD3, SOX10, and ERBB3.</div></div>
                            </div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Genes Checked</h3>
                            <div class="gene-list"><span class="gene-badge">GFAP</span><span class="gene-badge">CD34</span><span class="gene-badge">CD45</span><span class="gene-badge">KROX20</span><span class="gene-badge">MBP</span><span class="gene-badge">MPZ</span><span class="gene-badge">PMP22</span><span class="gene-badge">SNAI2</span><span class="gene-badge">FOXD3</span><span class="gene-badge">SOX10</span><span class="gene-badge">ERBB3</span></div>
                        </div>
                        
                        <div class="sub-section">
                            <h3>Key Findings</h3>
                            <div class="content">
                                High expression of ERBB3, FOXD3, MPZ, PMP22, and SOX10 was observed. MBP remained low. The continued absence of CD34, CD45, GFAP, KROX20, and SNAI2 from the differential expression list persisted, preventing definitive conclusions on glial maturity, specific myelinating commitment, and purity.
                            </div>
                        </div>
                    </section>
                
                <section class="final-annotation">
                    <h2>Final Annotation</h2>
                    <div class="content">
                        The final cell type is **Enteric Glial Cells, with a significant myelin-associated and immature/progenitor component.**

Confidence level: **Medium-High**
                    </div>
                </section>
        
                    <section>
                        <h2>Key Marker Genes</h2>
                        <div class="content">
                            *   **General Glial Identity:** S100B, PTPRZ1, L1CAM, NRXN1, NRXN3, CDH19, CHL1, CADM2.
*   **Neural Crest/Developmental:** SOX10, FOXD3, SOX2, NES, NGFR.
*   **Myelin-Associated/Myelinating:** PLP1, MPZ, PMP22.
*   **Metabolic/Supportive/Reactive:** LPL, SPP1, APOE, CLU, CST3.
*   **Immature/Plasticity:** ERBB3.
                        </div>
                    </section>
                
                    <section>
                        <h2>Recommendations</h2>
                        <div class="content">
                            The user should prioritize obtaining expression data for GFAP, KROX20, CD34, and CD45. GFAP is needed to confirm glial maturity, KROX20 for myelinating commitment, and CD34/CD45 to confirm cluster purity. Further sub-clustering based on myelin-associated (PLP1, MPZ, PMP22, KROX20) versus immature/progenitor (SOX2, NES, NGFR, ERBB3) markers is recommended to delineate distinct glial subtypes.
                        </div>
                    </section>
                
            </div>
        </body>
        </html>
        